Testing effectiveness (Phase 2)Ended earlyNCT03953456
What this trial is testing
Study to Evaluate the Effect of Elafibranor on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty Liver (NAFL)
Who this might be right for
Non-Alcoholic Fatty Liver
Genfit 17